The F-actin side binding activity of the Arp2/3 complex is essential for actin nucleation and lamellipod extension  by Bailly, Maryse et al.
620 Brief Communication
The F-actin side binding activity of the Arp2/3 complex is essential
for actin nucleation and lamellipod extension
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Laura M. Machesky†, Jeffrey E. Segall* and John Condeelis*
Most eukaryotic cells rely on localized actin Results
Although the nucleation activity of the Arp2/3 complexpolymerization to generate and sustain the
protrusion activity necessary for cell movement has been extensively explored [5–7, 9–11, 30, 31], the
branching activity of the complex, an essential step in the[1, 2]. Such protrusions are often in the form of a
flat lamellipod with a leading edge composed of a dendritic nucleation model [5], is much less well charac-
terized, particularly in terms of its relevance in vivo. Whiledense network of actin filaments [3, 4]. The Arp2/3
complex localizes within that network in vivo [3, 4] it seems clear now that the branching occurs during poly-
merization rather than after [6, 7], branching has beenand nucleates actin polymerization and generates a
branched network of actin filaments in vitro [5–7]. modeled in two ways, either as a separate activity of the
Arp2/3 complex [5, 6, 30] or as an integral part of theThe complex has thus been proposed to generate
the actin network at the leading edge of crawling nucleation mechanism [7]. Furthermore, the complex
does indeed localize at Y branches of actin filaments incells in vivo [3, 4, 8]. However, the relative
contributions of nucleation and branching to vivo [3, 4], but multiple other actin cross-linking proteins
are present at the leading edge that could also causeprotrusive force are still unknown. We prepared
antibodies to the p34 subunit of the Arp2/3 branching [12, 13], and there is no direct evidence that
the branching activity of the Arp2/3 complex is requiredcomplex that selectively inhibit side binding of the
complex to F-actin. We demonstrate that side for the extension of the lamellipod.
binding is required for efficient nucleation and
branching by the Arp2/3 complex in vitro. However, Structural studies of the Arp2/3 complex from Acantha-
microinjection of these antibodies into cells moeba using chemical cross-linking have shown that of
specifically inhibits lamellipod extension without the seven subunits of the complex, only two, Arp3 and
affecting the EGF-stimulated appearance of free p35, seem to bind actin directly [14]. The atomic model
barbed ends in situ. These results indicate that of Arp3, based on its sequence homology to actin, predicts
while the side binding activity of the Arp2/3 complex that this subunit is likely to be involved in the nucleation
is required for nucleation in vitro and for protrusive function of the complex by forming a heterodimer with
force in vivo, it is not required for EGF-stimulated Arp2 that could serve as a pointed end nucleus for actin
increases in free barbed ends in vivo. This suggests polymerization [14, 15]. The p35 subunit, on the other
that the branching activity of the Arp2/3 complex is hand, is a potential candidate for binding to the side of
essential for lamellipod extension, while the the actin filament, since it binds actin but is not obviously
generation of nucleation sites for actin involved in the nucleation activity [14]. We have gener-
polymerization is not sufficient. ated a peptide antibody against p34, the human homolog
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rating amounts of AE360 antibodies inhibit the ability of
the Arp2/3 complex to nucleate actin polymerization in
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Figure 1
The effect of AE360 anti-p34 antibody on the
nucleation and side binding functions of the
Arp2/3 complex. (a) Immunolocalization of the
p34 subunit of the Arp2/3 complex using
AE360 antibodies. The scale bar indicates 10
mm. Inset, an immunoblot showing the
immunoprecipitation of the p34 subunit of the
Arp2/3 complex from whole cell lysates using
AE360 antibodies. Lane 1, AE360 antibodies;
lane 2, control beads without IgG; the black
mark indicates 36.5 kDa molecular weight
marker. (b) Nucleation assay in vitro: 3 mM
actin (5% pyrene-labeled), 10 nM Arp2/3, and
10 nM GST-VCA (squares, 40:1 ratio of
antibodies to Arp2/3) or 2 mM actin, 2 nM
Arp2/3, 2 nM GST-VCA (circles, 200:1 ratio
of antibodies to Arp2/3) were incubated in the
presence of either 400 nM AE360 anti-p34
antibodies (closed symbols) or an equal
volume of TBS buffer (open symbols) at 228C
in polymerization buffer (2 mM Tris [pH 8], 0.2
mM CaCl2, 0.02% NaN3, 0.2 mM ATP, 0.5
mM DTT, 1 mM EGTA, 2 mM MgCl2, and
50 mM KCl). (c) The Arp2/3 complex-actin
cosedimentation assays: 4 mM F-actin, 0.25
mM Arp2/3 complex, 0.25 mM antibodies as
specified, in 5 mM imidazole (pH 7.0), 50
mM KCl, 1 mM MgCl2, 0.2 mM ATP, and 1
mM EGTA. The graph shows the percentage
of the Arp2/3 complex that is bound to F-actin phase in nucleation by the Arp2/3 complex. 400 s (circles), and 700 s (triangles) after
after 30 min of incubation at 228C in the The Arp2/3 complex (27 nM) and GST-VCA initiation of polymerization in the presence of
presence of the respective antibodies. (d) The (100 nM) were added to polymerizing actin (4 500 nM nonimmune IgG (open symbols) or
effect of AE360 antibodies on the lag mM, 5% pyrene-labeled) at 0 s (squares), AE360 antibodies (closed symbols).
the presence of the N-WASP-derived GST-VCA fragment To determine if AE360 antibodies were directly affecting
the branching activity of the Arp2/3 complex, we designed(Figure 1b). The side binding activity of the purified
complex was evaluated in a sedimentation assay using 4 mm an electron microscope-based assay to visualize and quan-
tify the branching activity and filament lengths in theF-actin and 0.25 mm Arp2/3 complex, conditions under
which the Arp2/3 complex binds to the side of the actin presence of the Arp2/3 complex. In the absence of the
Arp2/3 complex (and in the presence of control antibodiesfilament [5, 14]. Under these conditions, the addition of
concentrations of AE360 antibodies equimolar to the at a molar ratio of about 10 molecules of antibody to what
would be 1 molecule of the complex in the experimentalArp2/3 complex inhibited the binding of the Arp2/3 com-
plex to actin filaments (Figure 1c). The addition of pre- sample), actin polymerized as long unbranched filaments
(average filament length 5 0.53 6 0.05 mm), with theformed actin filaments has been shown to reduce the lag
phase of Arp2/3 complex-mediated nucleation, suggesting occasional overlapping of filaments resulting from the
negative-staining procedure (Figures 2a,d). In the pres-that the binding of the Arp2/3 complex to the sides of
actin filaments promotes nucleation [18, 19, 30]. While ence of the Arp2/3 complex activated by the GST-VCA
fragment and control nonimmune IgG, the preparationthe nucleation-promoting activity of actin filaments on
the Arp2/3 complex was observed in the presence of non- consisted of many short filaments (average filament
length 5 0.30 6 0.01 mm), with a 4-fold increase inimmune IgG, the addition of AE360 antibodies at a satu-
rating concentration (20 moles antibodies: 1 mole Arp2/3 branching (Figures 2b,d). However, when the AE360 anti-
body against p34 was added to the preparation at the samecomplex) drastically inhibited the ability of actin fila-
ments to stimulate Arp2/3-mediated nucleation and ex- molar ratio as the nonimmune IgG used in the control,
branching was drastically inhibited and correlated withtended the nucleation lag phase (Figure 1d). This is con-
sistent with the ability of this antibody to inhibit the the reappearance of longer unbranched filaments (average
filament length 5 0.53 6 0.02 mm) (Figures 2c,d). Thesebinding of the Arp2/3 complex to the sides of actin fila-
ments and represents the first direct verification of the results demonstrate that this antibody directly affects the
ability of the Arp2/3 complex to bind the sides of actinproposal that side binding of the complex stimulates nu-
cleation [18, 19]. filaments to form branches and to nucleate filaments. To
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Figure 2
The effect of AE360 anti-p34 antibodies on
the branching activity of the Arp2/3 complex
as measured in electron and light microscope
assays. (a–d) Observations of the actin
filaments in the electron microscope.
Conditions: 4 mM actin, 4 mM phalloidin, 425
nM GST-VCA, and 300 nM antibodies. Actin
filaments polymerized for 30 min in the
presence of (a) nonimmune IgG, (b) 75 nM
Arp2/3 complex and nonimmune IgG, and
(c) 75 nM Arp2/3 complex and anti-p34
antibodies. The arrows point at typical
branching. The scale bar indicates 0.2 mm. (d)
Quantitation of the branching (number of
branches per mm of filament): actin 1 IgG
(n 5 1472), actin 1 Arp2/3 1 IgG (n 5
2181), actin 1 Arp2/3 1 anti-p34 (n 5 5038);
significant difference (p 5 1.3x1026). (e–h)
Direct observation of actin filaments in the light
microscope. Conditions: 2 mM actin, 200 nM
phalloidin, 40 nM GST-VCA, and 40 nM Arp2/3.
Actin filaments polymerized for 20 min in
the presence of (e) TBS buffer blank, (f) 400
nM anti-p34 antibodies, and (g) 800 nM anti- and number of branched filaments (per field, 1200 nM nonimmune IgG to ensure that IgG
p34 antibodies. The scale bar indicates 5 mm. mean 6 SEM.). Additional control chambers has no nonspecific effect on actin binding to
(h) Quantitation of the total filament number were perfused with actin in the presence of nitrocellulose (data not shown).
analyze this further, we used a light microscope assay to mg/ml) into MTLn3 cells totally abolished the cells’ abil-
ity to extend lamellipods in response to EGF stimulationdirectly measure the filament number and mass [6, 30].
As shown in Figures 2e–g, AE360 antibody inhibited the (Figure 3). As previously reported [23], microinjection
of control nonimmune IgG did not affect EGF-stimulatedability of the Arp2/3 complex to increase the number of
filaments (684 6 20 filament/field for the control experi- lamellipod extension. In addition, the overall cell mor-
phology was not significantly affected by either of thement without anti-p34 antibody, 256 6 21 filaments/field
after the addition of 400 nM AE360 antibody, and 75 6 microinjected antibodies, and the cells remained spread
13 filaments/field for the experiment with 800 nM AE360
antibody present), the number of filaments with branches Figure 3
(64%, 50%, and 15% of branched filaments, respectively),
and the total filament mass (4.24 6 0.24(100%), 2.15 6
0.12(51%), and 0.54 6 0.05(13%) of rhodamine fluorescence
[a.u.]/field, respectively). The addition of equal amounts
of nonimmune IgG had no effect on these parameters.
Altogether, these results combined to demonstrate that
the two functions of the Arp2/3 complex, i.e., nucleation
and branching, are linked and provided us with a tool to
directly determine the importance of the Arp2/3 complex
in free barbed end generation and protrusive force in vivo.
MTLn3 mammary carcinoma cells extend flat circumfer-
ential lamellipods within minutes after stimulation with
Inhibition of lamellipod extension after microinjection of AE360 anti-epidermal growth factor [20, 21]. These extensions are
p34 antibodies. Left panel; (a,c) morphology of control noninjecteddependent on actin polymerization at the edge of the cells, and (b,d) cells microinjected with AE360 anti-p34 antibodies
lamellipods. This polymerization activity is supported by immediately (a, b) before and (c,d) 3 min after EGF stimulation.
Lamellipod extension is shown on control cells (arrowheads). Righta transient increase in free barbed ends, which is confined
panel; quantitation of the protrusive activity after EGF stimulation into a narrow zone at the extreme leading edge of the
cells 30–45 min after antibody microinjection, measured as describedlamellipods [3, 22]. We sought to analyze the effect of previously [3, 21]. Triangles, AE360 anti-p34 antibodies (n 5 14);
AE360 antibody on barbed end generation and lamellipod squares, nonimmune IgGs (n 5 75); and diamonds, control mock-
injected cells (n 5 17). SEM , 5%.extension in vivo by microinjecting cells prior to stimula-
tion with EGF. Microinjection of the AE360 antibody (2
Brief Communication 623
Figure 4 protrusive activity, since lamellipod extension is totally
abolished by the AE360 branch-inhibiting antibodies.
The generation of free barbed ends in cells in response
to EGF stimulation was unaffected by the inhibition of
Arp2/3 activities with the AE360 antibodies. Previous
work has implicated severing by cofilin in the generation
of free barbed ends in these EGF-stimulated cells, and
the results presented here are consistent with these find-
ings [23, 28].
Previous work had shown that cross-linking of actin fila-
Barbed end number and distribution in vivo after microinjection of
ments is an essential step in lamellipod extension, sinceAE360 anti-p34 antibodies. Biotin-labeled actin (0.45 mM) was
deletion of members of the filamin family of actin cross-incorporated into permeabilized cells to visualize free barbed ends [3,
23] for actin polymerization after stimulation, and incorporation at the linking proteins from cells inhibits pseudopod extension
leading edge was quantified 30 s and 60 s after EGF stimulation by (see [24] for a recent review). Indeed, the three-dimen-
measuring the fluorescence intensity within 1.1 mm at the leading sional architecture of the actin cytoskeleton in the lamelli-edge [3]. (a) exogenous-labeled actin incorporation at the leading
pods of MTLn3 cells used here [3] is consistent with theedge of cells microinjected with AE360 anti-p34 antibodies after 1
min of EGF stimulation (the arrow points to the microinjected cell). orthogonal cross-linking of actin filaments by members
The scale bar indicates 20 mm. (b) The relative number of barbed of the filamin family [12, 24, 25], and at least one of the
ends at the leading edge. White columns, control cells in the field filamins, ABP 280, is localized within the actin network(n 5 8–30); and gray columns, cells microinjected with anti-p34
in lamellipods of these cells [3]. However, the results weantibodies (n 5 10–27). Mean 6 SEM.
present here indicate that the actin cross-linking proteins
present in lamellipods cannot compensate for the branching
activity of the Arp2/3 complex since the specific inhibition
(Figure 3). These results are consistent with the proposed of the Arp2/3 complex’s branching activity is sufficient
importance of the branching activity of the Arp2/3 com- to inhibit lamellipod extension, even in the presence of
plex for protrusive force. However, unexpectedly, neither free barbed ends. Hence, our results demonstrate that the
the location nor the amount of nucleation sites for actin Arp2/3 complex provides the cross-linking activity that is
polymerization was significantly altered in EGF-stimu- required to branch polymerizing filaments in the nucle-
lated cells after microinjection with anti-p34 antibodies ation zone [3, 5, 8, 23], which is necessary for protrusive
(Figure 4). This indicates that other pathways exist that force [26]. Additional cross-linking by members of the
do not involve the side binding-dependent nucleation filamin family might contribute to structural stability more
activity of the Arp2/3 complex for the generation of free distally as the actin network grows and moves centripe-
barbed ends in response to EGF stimulation. tally relative to the membrane in the advancing lamel-
lipod.
Discussion
We provide here a direct demonstration that the nucle-
ation and branching activities of the Arp2/3 complex are Conclusions
We have prepared an antibody against the p34 subunitlinked. This is in accordance with previous results show-
ing that preformed actin filaments enhance Arp2/3 com- of the Arp2/3 complex that specifically inhibits the bind-
ing of the complex to the sides of actin filaments. In vitro,plex-mediated nucleation of actin polymerization [18, 19].
Our results support the previous interpretation that the this antibody inhibits the nucleation activity of the Arp2/3
complex, confirming that side binding and nucleation areability of F-actin to overcome the lag in Arp2/3 nucleation
is due to side binding, as proposed by Machesky et al. linked activities. In vivo, the antibody inhibits protrusive
activity, but not EGF-stimulated barbed ends, indicat-[18] and Higgs et al. [19]. Altogether, our findings support
the original dendritic nucleation model for Arp2/3 com- ing that the branching activity of the Arp2/3 complex is
essential for protrusive force, that other actin cross-link-plex-mediated network formation in which branches are
formed by nucleation on the side of an existing actin ing proteins cannot compensate for this activity, and that
free barbed ends are not sufficient for protrusive force.filament [5, 30]. Furthermore, our results demonstrate
that the generation of nucleation sites for actin polymer- The failure of the antibody to inhibit the generation of
barbed ends in vivo indicates that Arp2/3-independentization, although necessary [22, 23], is not sufficient for
lamellipod extension. The binding of the Arp2/3 complex pathways are present in EGF-treated cells for the stimula-
tion of actin polymerization. This conclusion is consistentto the sides of the actin filaments and the generation of
branches appears, on the other hand, to be essential for with previous work implicating severing by cofilin as the
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For the direct visualization of actin nucleation by light microscopy, 2 mMgenerator of free barbed ends in EGF-stimulated cells [3,
rhodamine-labeled actin was polymerized for 20 min at room temperature23, 28].
in polymerization buffer with 40 nM Arp2/3, 40 nM GST-VCA, and 200
nM phalloidin in the presence of varying amounts of AE360 antibody in
the same volume of TBS buffer. Rabbit muscle capping protein (10 nM)Material and methods
was added at the beginning of the polymerization reaction to limit filamentProtein purification
length. Longer filaments significantly complicate quantative analysis ofActin was purified from rabbit skeletal muscle acetone powder, and
LM images. Polymerized actin was diluted 1:15 with polymerization bufferthe Arp2/3 complex was purified from human platelets [27]. Human
and incubated for 5 min over the nitrocellulose-covered coverslip “cham-N-WASP-VCA domain was expressed in bacteria and purified as a GST-
ber”. Unbound actin was washed away with ISAP buffer containingtagged fragment. Pyrene actin was made as previously described [22].
antibleaching reagents, and images were taken with a CCD cameraPolyclonal antibodies against p34 were generated by immunizing rabbits
mounted on an Olympus IX70 microscope as previously described [29].with MAP-peptides with the following sequence: EKKEMKTITGKTFS
Four fields of view were randomly captured with a 603 objective from(amino acids 286–298). The IgG fraction was isolated using T-Gel
different parts of the slide for every experimental condition. The images(Pierce) and further purified by affinity chromatography against the pep-
were analyzed, and filament parameters were scored using NIH Imagetide immunogen. Nonimmune rabbit IgGs were obtained from Sigma
software. The F-actin mass was scored in arbitrary units based on rhoda-and further purified on T-Gel. Immunofluorescence was performed using
mine fluorescence intensity.AE360 anti-p34 antibodies followed by FITC-labeled anti-rabbit second-
ary antibodies as previously described [21].
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